Latest Updates

Interview

Diasome's Liver Targeted Insulin with Robert Geho

April 18, 2019

Share this article
Interview

Latest Updates

News

Press Release

Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes

View Article
Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

View Article
View All